It is time for the Doc to deliver There is a lot of information...

First 2079 Last

Share
Profile

Follow
Dingo59

936 Posts.

145

01/06/20

23:52

Post #: 44972132
Share

Originally posted by Brett M H: ↑

@ Idisley - g'day!!

I think the answer to the lack of current Prizma marketing is they probably don't have the ability to manufacture enough stock right now - even at current demand levels.

They are probably flat out just keeping up with the orders coming in now - albeit that we have no clue if this is only 5 x Prizma & 5 x Patch orders per day (or if it is 1,000 orders for each product that are coming in each day)???

@ nocluegsb - with regards to your earlier post, having owned this stock for a few years I am still not aware of any information that has been released by GMV yet that states:

1. What the manufacturing capacity of our Israel factory actually is?
2. Who the approved "manufacturing partner" in Israel is (that are now manufacturing GMV's products as per one of the latest announcements)?
3. What the manufacturing capacity of GMV's "manufacturing partner" actually is?
4. If GMV's Israel factory can actually manufacture both the Patch & Prizma? There was a train of thought that the Israel factory can only produce the Patch - but I am not sure if this is the case?

I may have missed this information when it was released, but I don't think so?

I think it was mentioned that the China factory (when fully operational) could make a large amount of Prizmas - something like 1,000 x Prizmas per day.

But I am sure that Glyco or others could confirm this number for you.

I have never seen any numbers showing how many Patches the GMV manufacturing plant in China can make?

Hope that helps a little!!

Expand

It is time for the Doc to deliver
There is a lot of information required here time for an update .

D.

GMV Price at posting: 6.6¢ Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

MMI

Metro Mining inks bauxite offtake contracts into 2026 with Chinese m

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Trump is President Again: What Does This Mean for Crypto?

Trump Victory Sends Bitcoin Surging Above $75K – Is $100K Next?

FG1

Flynn Gold reaches milestone exploration target for Golden Ridge

Week 45 Wrap: Combat sports usher in Trump 2.0 – or is it male insecurity?; RBA boring; Propane suggests China alive

HotCopper Highlights: Your most watched and most discussed stocks this week

UBI

Universal Biosensors flat despite fresh deal with US medical product distributor

IMU

Imugene kicks off Australian trial for blood cancer treatment